In the recent analyze, we reported the identification along with the characterization of a new atypical opioid receptor with distinctive adverse regulatory Qualities toward opioid peptides.1 Our effects showed that ACKR3/CXCR7, hitherto often called an atypical scavenger receptor for chemokines